Highest-materiality recent filing
UFP Technologies appoints Mitchell Rock as CEO, Ryan Stafford as General Counsel & SVP HR
Mitchell C. Rock appointed CEO and joins Board effective June 4, 2026.
UFP Technologies provides updated investor presentation for June 2026
Updated investor presentation furnished under Item 7.01; no material financial updates disclosed.
All seven director nominees elected: R. Jeffrey Baily, Thomas Oberdorf, Marc Kozin, Daniel C. Croteau, Cynthia L. Feldmann, Joseph John Hasset, Symeria Hudson.
UFP Technologies GC Christopher Litterio plans retirement after transition (notified May 19, 2026)
Christopher P. Litterio, General Counsel, Secretary, and Senior Vice President of Human Resources, informed UFP Technologies on May 19, 2026 of his intention to retire after a transition period.
UFP Technologies Q1 net income $17.5M, revenue up 4.1% to $154.2M
GAAP EPS $2.24, adjusted EPS $2.48; net income up 1.8% YoY from $17.2M.
UFP Technologies files updated investor presentation; no material changes disclosed
Filed 8-K furnishing updated investor presentation under Item 7.01.
UFP Technologies reports record 2025 sales of $602.8M, EPS $8.75
Net income $68.3M (+15.8% YoY); adjusted net income $76.1M (+12.7%).
UFP Technologies detects cyber incident; data exfiltrated, systems mostly restored
On Feb 14, 2026, UFP detected unauthorized access; third party removed and access restored in all material respects.
UFP Tech extends supply pact with Intuitive Surgical to 2029, boosts min volumes
Amendment No. 27 extends Manufacturing Supply Agreement term by two years, now through Dec 31, 2029.
UFP Technologies appoints Mitchell C. Rock as CEO effective June 4, 2026; base salary $700k
Mitchell C. Rock appointed CEO effective June 4, 2026; base salary $700k, annual bonus target up to 100% of base.
UFP Technologies CEO Bailly to retire June 2026; President Rock to succeed
R. Jeffrey Bailly will retire as CEO effective June 4, 2026, after 31 years as CEO.
UFP Technologies posts updated investor presentation; no specific financial disclosures in excerpt
Updated investor presentation (Exhibit 99.1) released for meetings starting December 2025.
UFP Technologies Q3 EPS flat at $2.11; sales up 6.5% but organic sales flat due to labor issue
Q3 net income $16.4M ($2.11 diluted EPS), flat YoY; adjusted EPS $2.39.
UFP Technologies files updated investor presentation under Regulation FD
Furnished investor presentation under Item 7.01; no financial results disclosed.
UFP Technologies Q2 2025: Record net income $17.2M; sales up 37% YoY; completed two acquisitions
Net income of $17.2M ($2.21 diluted EPS) vs $13.6M ($1.75) in Q2 2024; adjusted EPS $2.50 (+27%).
UNIPEC acquired for $7.5M cash; ~3.75x adj. EBITDA; $5M revenue, $2M EBITDA.
UFP Technologies furnishes investor presentation; no material new data disclosed
Presentation filed under Regulation FD for use in investor meetings.
Stockholders elected all seven director nominees; highest vote count for Symeria Hudson at 6,311,434 for.
UFP Technologies reports record Q1: revenue $148.1M (+41%), net income $17.2M (+35%), EPS $2.21
Net sales $148.1M vs $105.0M (+41.1%); MedTech sales up 50.4% to $135.4M.
AJR Enterprises subsidiary signs two exclusive supply agreements with Sage Products (Stryker) for manufacturing rights.
UFP Technologies' MedTech COO Steve Cardin resigns, effective March 28
Steve Cardin, VP and COO of MedTech business, resigned effective March 28, 2025.
UFP Technologies reports record 2024 revenue of $504.4M, adj. EPS $8.68, up 31%
Full-year net income $59.0M (+31.3%); adjusted net income $67.6M (+32.5%); GAAP EPS $7.58, adj. EPS $8.68.
UFP Technologies approves FY2025 executive base salary increases and stock unit awards
CEO Bailly base salary raised to $789,000; President Rock to $525,000; CFO Lataille to $485,000, effective Jan 1, 2025.
UFP Technologies Q3 net income up 40% to $16.4M, sales up 44% to $145.2M
Net income rose 40% to $16.4M vs $11.7M YoY; adjusted net income up 46.5% to $18.6M.
UFP Technologies acquires AQF Medical for €43M; 12.3x EBITDA multiple
Purchase price €43.0M cash; multiple ~12.3x adjusted EBITDA for 12 months ended June 30, 2024.
UFP Technologies posts updated investor presentation; no specific new facts disclosed
Company issued an updated investor presentation (August 2024) for use in meetings with investors and other parties.
UFP Technologies Q2 net income $13.6M ($1.75 EPS), revenue up 10% to $110.2M; acquires three firms
Net income $13.6M ($1.75 diluted EPS) vs $11.9M ($1.55) in Q2 2023, up 14.0%.
Welch Fluorocarbon acquired for $34.6M cash plus up to $6M earnout based on 2024-2026 EBITDA targets; ~11.5x adjusted EBITDA.
UFP Technologies acquires AJR Enterprises for $110M; finances with new $275M credit facility
Purchase price $110M cash; AJR generated ~$75M sales and ~$18.3M adjusted EBITDA TTM ended Mar 31, 2024.
UFP Technologies files updated investor presentation, no specific financial data disclosed
Presentation intended for use in investor meetings and speeches.
All seven director nominees elected; R. Jeffrey Bailly received 6,218,977 votes for, 342,484 withheld.
UFP Technologies Q1 net income up 30% to $12.7M; EPS $1.64; sales $105M (+7.4%)
Diluted EPS of $1.64 vs $1.27 in Q1 2023; net income $12.7M vs $9.7M.
Amended manufacturing supply agreement with Intuitive Surgical SARL, effective Jan 1, 2024, for a four-year initial term.
UFP Technologies reports record 2023; EPS up 7% to $5.83, sales +13.1%
FY2023 net sales $400.1M (+13.1% YoY); net income $44.9M ($5.83 diluted EPS) vs $41.8M ($5.45).
UFP Technologies appoints Mitchell Rock as President; CEO Bailly remains Chairman and CEO
Mitchell Rock appointed President effective Feb 6, 2024; previously President of UFP MedTech.
UFP Technologies posts updated investor presentation for November 2023
Company furnished presentation materials for use in meetings with investors.
UFP Technologies Q3 adjusted net income up 13.8% to $11.9M; sales $100.8M
Sales Q3 $100.8M (+3.9% YoY); YTD $298.6M (+13.7%). Organic growth 5.6% in Q3.
UFP Technologies furnishes updated investor presentation; no new financial data disclosed
Filed 8-K to furnish updated investor presentation under Regulation FD dated August 2023.
UFP Technologies posts record Q2: net income $11.9M, EPS $1.55, sales $100M
Net income $11.9M ($1.55 diluted EPS) vs $8.9M ($1.17) in Q2 2022, up 34%.
Stockholders approved amendment to certificate of incorporation to add officer exculpation per Delaware law and remove Series A Preferred references.
UFP Technologies updates investor presentation; no material disclosures
Company furnished an updated investor presentation for use in June 2023 meetings.
UFP Technologies posts updated investor presentation; no material changes disclosed
Filed updated presentation materials for investor meetings on June 12, 2023.
UFP Technologies Q1 net income $9.7M ($1.27 EPS), revenue up 37% to $97.8M
Medical market sales surged 59.5% to $83.8M, led by 112% growth in robotic surgery.
UFP Technologies board adopts Second Amended and Restated Bylaws effective April 24, 2023
Amendments update stockholder nomination procedures to comply with SEC Universal Proxy Rules (Rule 14a-19).
UFP Technologies releases updated investor presentation for March 2023
Presentation covers business overview and strategy for investor meetings.
UFP Technologies reports record 2022 revenue $353.8M, EPS $5.45 (+160% YoY)
Full-year 2022 revenue $353.8M (+71.5% YoY); net income $41.8M ($5.45 diluted EPS) vs $15.9M ($2.09) in 2021.
UFP Technologies raises CEO base salary to $680k, grants $300k special bonus and stock options
Base salary increases effective Jan 1, 2023: CEO Bailly $680k, CFO Lataille $440k, SVP Litterio $355k, SVP Rock $440k, VP Cardin $325k.
UFP Technologies files updated investor presentation with no new financial data
Presentation furnished under Item 7.01; no material financial metrics or guidance disclosed.
UFP Technologies reports record Q3: EPS $2.56 vs $0.50, sales up 91% to $97M
Net income $19.5M ($2.56 diluted EPS) vs $3.8M ($0.50) in Q3 2021; sales $97.0M, up 91.2% YoY.
Company furnished updated investor presentation materials dated September 21, 2022.
Christopher P. Litterio, General Counsel, Secretary, and Senior Vice President of Human Resources, informed UFP Technologies, Inc., a Delaware corporation (the “ Company ”), that he plans to retire from the Company after a period of transition.
On June 4, 2026, the Company announced that it had appointed Ryan Stafford as the Company’s General Counsel, Senior Vice President of Human Resources, and Secretary, effective June 4, 2026.
appointment of Mitchell C. Rock as the Company’s Chief Executive Officer
On May 19, 2026, Christopher P. Litterio, General Counsel, Secretary, and Senior Vice President of Human Resources, informed UFP Technologies, Inc., a Delaware corporation (the “ Company ”), that he plans to retire from the Company after a period of transition .
On March 15, 2025, Steve Cardin, Vice President and Chief Operating Officer of the MedTech business of UFP Technologies, Inc., a Delaware corporation (the “Company”), tendered his resignation from the Company.
On February 6, 2024, the Board of Directors (the “Board”) of UFP Technologies, Inc. (the “Company”) appointed Mitchell C. Rock to President of the Company, effective immediately.
Effective as of December 31, 2021, Daniel J. Shaw, Jr., Vice President of Research and Development at UFP Technologies, Inc., a Delaware corporation (the “Company”), will be retiring from his position with the Company.
Max materiality 0.85 · Median 0.55 · Most common event earnings